Anatara raises A$7M in Australian IPO

Anatara Lifesciences Ltd. (ASX:ANR), which is seeking partners for human development of its non-antibiotic therapy to treat and prevent diarrhea, raised A$7 million ($6.1 million) through the sale of 14 million shares at A$0.50 in an IPO on the Australian Stock Exchange.

The price values the company at $A18.9 million ($16.5 million). Trading on ASX is expected to begin this week. Wilson HTM and Peloton Capital were underwriters. ...